10:00 AM EDT, 09/17/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co (SASE:4016), d/b/a Avalon Pharma, renewed its one-year bank facility agreement amounting to 104 million Saudi riyals with Banque Saudi Fransi. The Tadawul-listed pharmaceutical company said Thursday the Sharia-compliant facility will be used to fund its working capital.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.